- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Treatment Pathways Across Cultures

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Treatment Pathways Across Cultures
Understanding the cultural aspects of treating bipolar disease offers invaluable insights into how diverse ethnic backgrounds influence the perception, diagnosis and the management of this condition. Appreciating these differences can improve communication between healthcare providers and patients and lead to more improved, personalized and effective healthcare treatment plans. During this webinar, Sr. MSL Dr. Michael Aldape will be talking with Dr. Crystal Clark and Dr. Mauricio Tohen as they guide us on a lively discussion addressing the impact of culture across treatment pathways for bipolar disorder, and how cultural context can be integrated into treatment strategies for this condition.

Michael Aldape, PhD
Senior Medical Science Liaison

Crystal T. Clark, MD, MSc
Associate Professor, Department of Psychiatry, University of Toronto; Research Investigator, Associate Head of Research, Department of Psychiatry, Women’s College Hospital (Toronto, Ontario)
More

Mauricio Tohen, MD, DrPH, MBA
Chairman, Department of Psychiatry and Behavioral Sciences, Distinguished University Professor, University of New Mexico
More
Dr. Michael Aldape, PhD, Dr. Mauricio Tohen, MD, DrPH, MBA and Dr. Crystal Clark, MD, MSc are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
September 2024 US.CORP.X.24.00280